{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T22:05:13Z","timestamp":1793397913625,"version":"4.5.0"},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,9]]},"abstract":"<jats:sec>\n                    <jats:title>OBJECTIVE:<\/jats:title>\n                    <jats:p>To assess trends in polysubstance use among pregnant women with opioid use disorder in the United States.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS:<\/jats:title>\n                    <jats:p>We conducted a time trend analysis of pooled, cross-sectional data from the National Inpatient Sample, an annual nationally representative sample of U.S. hospital discharge data. Among 38.0 million females aged 15\u201344 years with a hospitalization for delivery from 2007 to 2016, we identified 172,335 pregnant women with an International Classification of Diseases, Ninth Revision, Clinical Modification or International Classification of Diseases, Tenth Revision, Clinical Modification diagnosis of opioid use disorder. Polysubstance use among pregnant women with opioid use disorder was defined as at least one co-occurring diagnosis of other substance use, including alcohol, amphetamine, cannabis, cocaine, sedative, or tobacco. We fit weighted multivariable logistic regression models to produce nationally representative estimates, including an interaction between year and rural compared with urban county of residence; controlled for age, race, and insurance type. Average predicted probabilities and 95% CIs were derived from regression results.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS:<\/jats:title>\n                    <jats:p>Polysubstance use among women with opioid use disorder increased from 60.5% (95% CI 58.3\u201362.8%) to 64.1% (95% CI 62.8%\u201365.3%). Differential time trends in polysubstance use among women with opioid use disorder were found in rural compared with urban counties. Large increases in amphetamine use occurred among those in both rural and urban counties (255.4%; 95% CI 90.5\u2013562.9% and 150.7%; 95% CI 78.2\u201352.7%, respectively), similarly to tobacco use (30.4%; 95% CI 16.9\u201345.4% and 23.2%; 95% CI 15.3\u201331.6%, respectively). Cocaine use diagnoses declined among women with opioid use disorder at delivery in rural (\u221270.5%; 95% CI \u221280.4% to \u221255.5%) and urban (\u221261.9%; 95% CI \u221267.6% to \u221255.1%) counties. Alcohol use diagnoses among those with opioid use disorder declined \u221257% (95% CI \u221270.8% to \u221237.7%) in urban counties but did not change among those in rural counties.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSION:<\/jats:title>\n                    <jats:p>Over the past decade, polysubstance use among pregnant women with opioid use disorder has increased more rapidly in rural compared with urban counties in the United States, with amphetamines and tobacco use increasing most rapidly.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/aog.0000000000003907","type":"journal-article","created":{"date-parts":[[2020,8,6]],"date-time":"2020-08-06T12:02:22Z","timestamp":1596715342000},"page":"556-564","source":"Crossref","is-referenced-by-count":74,"title":["Polysubstance Use Among Pregnant Women With Opioid Use Disorder in the United States, 2007\u20132016"],"prefix":"10.1097","volume":"136","author":[{"given":"Marian P.","family":"Jarlenski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole C.","family":"Paul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth E.","family":"Krans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2020,8,5]]},"reference":[{"key":"R1-20230713","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/AOG.0000000000002054","article-title":"Opioid use in pregnancy NAS, childhood outcomes workshop invited S. Opioid use in pregnancy, neonatal abstinence syndrome, and childhood outcomes: executive summary of a joint workshop by the Eunice Kennedy Shriver National Institute of Child Health and Human Development, American College of Obstetricians and Gynecologists, American Academy of Pediatrics, Society for Maternal-Fetal Medicine, Centers for Disease Control and Prevention, and the March of Dimes Foundation","volume":"130","author":"Reddy","year":"2017","journal-title":"Obstet Gynecol"},{"key":"R2-20230713","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1001\/jamapsychiatry.2014.366","article-title":"The changing face of heroin use in the United States: a retrospective analysis of the past 50 years","volume":"71","author":"Cicero","year":"2014","journal-title":"JAMA Psychiatry"},{"key":"R4-20230713","doi-asserted-by":"crossref","first-page":"244","DOI":"10.2105\/AJPH.2019.305412","article-title":"Polysubstance use: a broader understanding of substance use during the opioid crisis","volume":"110","author":"Cicero","year":"2020","journal-title":"Am J Public Health"},{"key":"R5-20230713","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.2105\/AJPH.2017.303825","article-title":"Polysubstance use among US women of reproductive age who use opioids for nonmedical reasons","volume":"107","author":"Jarlenski","year":"2017","journal-title":"Am J Public Health"},{"key":"R6-20230713","doi-asserted-by":"crossref","first-page":"e1009","DOI":"10.1542\/peds.2012-3931","article-title":"Prenatal substance abuse: short- and long-term effects on the exposed fetus","volume":"131","author":"Behnke","year":"2013","journal-title":"Pediatrics"},{"key":"R8-20230713","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s10995-007-0256-6","article-title":"An enhanced method for identifying obstetric deliveries: implications for estimating maternal morbidity","volume":"12","author":"Kuklina","year":"2008","journal-title":"Matern Child Health J"},{"key":"R9-20230713","doi-asserted-by":"crossref","first-page":"845","DOI":"10.15585\/mmwr.mm6731a1","article-title":"Opioid use disorder documented at delivery hospitalization\u2014United States, 1999\u20132014","volume":"67","author":"Haight","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R10-20230713","first-page":"1","article-title":"2013 NCHS urban-rural classification scheme for counties","volume":"2","author":"Ingram","year":"2014","journal-title":"Vital Health Stat"},{"key":"R11-20230713","first-page":"1","article-title":"Potentially excess deaths from the five leading causes of death in metropolitan and nonmetropolitan counties\u2014United States, 2010-2017","volume":"68","author":"Garcia","year":"2019","journal-title":"Morb Mortal Wkly Rep Surveillance Summ"},{"key":"R14-20230713","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1093\/ije\/dyu029","article-title":"Estimating predicted probabilities from logistic regression: different methods correspond to different target populations","volume":"43","author":"Muller","year":"2014","journal-title":"Int J Epidemiol"},{"key":"R15-20230713","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1097\/AOG.0000000000003231","article-title":"Medication-assisted treatment use among pregnant women with opioid use disorder","volume":"133","author":"Krans","year":"2019","journal-title":"Obstet Gynecol"},{"key":"R16-20230713","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1097\/AOG.0000000000003381","article-title":"National partnership for maternal safety: consensus bundle on obstetric care for women with opioid use disorder","volume":"134","author":"Krans","year":"2019","journal-title":"Obstet Gynecol"},{"key":"R17-20230713","doi-asserted-by":"crossref","first-page":"e20173520","DOI":"10.1542\/peds.2017-3520","article-title":"Incidence and costs of neonatal abstinence syndrome among infants with Medicaid: 2004\u20132014","volume":"141","author":"Winkelman","year":"2018","journal-title":"Pediatrics"},{"key":"R18-20230713","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0376-8716(00)00136-8","article-title":"The effectiveness of two intensities of psychosocial treatment for cocaine dependence","volume":"61","author":"Coviello","year":"2001","journal-title":"Drug Alcohol Depend"},{"key":"R19-20230713","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1037\/0022-006X.66.5.832","article-title":"Superior efficacy of cognitive-behavioral therapy for urban crack cocaine abusers: main and matching effects","volume":"66","author":"Maude-Griffin","year":"1998","journal-title":"J Consult Clin Psychol"},{"key":"R20-20230713","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1300\/J069v16n02_05","article-title":"Intensive outpatient substance abuse treatment: comparisons with traditional outpatient treatment","volume":"16","author":"McLellan","year":"1997","journal-title":"J Addict Dis"},{"key":"R21-20230713","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.drugalcdep.2018.08.029","article-title":"Twin epidemics: the surging rise of methamphetamine use in chronic opioid users","volume":"193","author":"Ellis","year":"2018","journal-title":"Drug Alcohol Depend"},{"key":"R22-20230713","doi-asserted-by":"crossref","first-page":"148","DOI":"10.2105\/AJPH.2018.304771","article-title":"Amphetamine- and opioid-affected births: incidence, outcomes, and costs, United States, 2004\u20132015","volume":"109","author":"Admon","year":"2019","journal-title":"Am J Public Health"},{"key":"R23-20230713","doi-asserted-by":"crossref","first-page":"139.e1","DOI":"10.1016\/j.ajog.2010.10.004","article-title":"Methadone and perinatal outcomes: a retrospective cohort study","volume":"204","author":"Cleary","year":"2011","journal-title":"Am J Obstet Gynecol"},{"key":"R24-20230713","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1097\/AOG.0000000000002362","article-title":"Placental complications associated with psychostimulant use in pregnancy","volume":"130","author":"Cohen","year":"2017","journal-title":"Obstet Gynecol"},{"issue":"suppl 2","key":"R26-20230713","doi-asserted-by":"crossref","first-page":"S125","DOI":"10.1080\/14622200410001669187","article-title":"The epidemiology of smoking during pregnancy: smoking prevalence, maternal characteristics, and pregnancy outcomes","volume":"6","author":"Cnattingius","year":"2004","journal-title":"Nicotine Tob Res"},{"key":"R27-20230713","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1097\/ADM.0000000000000101","article-title":"Methamphetamines and pregnancy outcomes","volume":"9","author":"Wright","year":"2015","journal-title":"J Addict Med"},{"key":"R28-20230713","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1097\/ADM.0000000000000391","article-title":"Effect of methamphetamine hydrochloride on pregnancy outcome: a systematic review and meta-analysis","volume":"12","author":"Kalaitzopoulos","year":"2018","journal-title":"J Addict Med"},{"key":"R29-20230713","doi-asserted-by":"crossref","first-page":"j3326","DOI":"10.1136\/bmj.j3326","article-title":"Risk of neonatal drug withdrawal after intrauterine co-exposure to opioids and psychotropic medications: cohort study","volume":"358","author":"Huybrechts","year":"2017","journal-title":"BMJ"},{"key":"R30-20230713","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.drugalcdep.2017.08.001","article-title":"Maternal buprenorphine treatment and infant outcome","volume":"180","author":"Jansson","year":"2017","journal-title":"Drug Alcohol Depend"},{"key":"R31-20230713","first-page":"1","article-title":"Trends in smoking before, during, and after pregnancy\u2014pregnancy risk assessment monitoring system, United States, 40 sites, 2000-2010","volume":"62","author":"Tong","year":"2013","journal-title":"MMWR Surveill Summ."},{"key":"R32-20230713","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.drugalcdep.2012.11.019","article-title":"Cigarette smoking in opioid-dependent pregnant women: neonatal and maternal outcomes","volume":"131","author":"Jones","year":"2013","journal-title":"Drug Alcohol Depend"},{"key":"R33-20230713","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1080\/00952990903125235","article-title":"Smoking in pregnant women screened for an opioid agonist medication study compared to related pregnant and non-pregnant patient samples","volume":"35","author":"Jones","year":"2009","journal-title":"Am J Drug Alcohol Abuse"},{"key":"R34-20230713","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1111\/add.14651","article-title":"Accuracy of five self-report screening instruments for substance use in pregnancy","volume":"114","author":"Ondersma","year":"2019","journal-title":"Addiction"},{"key":"R35-20230713","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1097\/AOG.0000000000003230","article-title":"Accuracy of three screening tools for prenatal substance use","volume":"133","author":"Coleman-Cowger","year":"2019","journal-title":"Obstet Gynecol"},{"key":"R36-20230713","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1093\/jat\/bkv133","article-title":"A retrospective analysis of urine drugs of abuse immunoassay true positive rates at a national reference laboratory","volume":"40","author":"Johnson-Davis","year":"2016","journal-title":"J Anal Toxicol"},{"key":"R37-20230713","first-page":"1","article-title":"Trends in out-of-hospital births in the United States, 1990\u20132012","author":"MacDorman","year":"2014","journal-title":"NCHS Data Brief"}],"container-title":["Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/AOG.0000000000003907","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,13]],"date-time":"2023-07-13T13:07:09Z","timestamp":1689253629000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/AOG.0000000000003907"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,5]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/aog.0000000000003907","relation":{},"ISSN":["0029-7844"],"issn-type":[{"value":"0029-7844","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8,5]]}}}